News

Enter your email address to get Core One Labs News Alerts.
Company News
February 24, 2021
Core One Labs Finalizes Deal to Acquire Ketamine Infusions Centers of Texas, Entering the US Market for Psychedelic Treatments
Vancouver, British Columbia, Canada – February 23, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) a research and technology company focused...
Read more
Company News
February 10, 2021
Core One Labs Highlights Key Points From International Investor Call
Vancouver, British Columbia, Canada – February 10, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (“Core One” the “Company”)...
Read more
Company News
February 10, 2021
Core One Labs Prepares First in Series of Patent Applications
Vancouver, British Columbia, Canada – February 10, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core...
Read more
Company News
February 09, 2021
Core One Labs Announces Adding Video Conference Capabilities to Teleconference Call Scheduled for February 10, 2021 1:30 p.m. PST/4:30 p.m. EST
Vancouver, British Columbia, Canada – February 9, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
February 06, 2021
Core One Labs Engages Donohoe Advisory for Nasdaq Listing and Schedules Special Investor Call with Dr. Robert E.W. Hancock to Demonstrate Recent Research Outcome
Vancouver, British Columbia, Canada – February 6, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) announces that it has engaged Donohoe Advisory Associates...
Read more
Company News
February 04, 2021
Core One Labs Announces Its Entrance into the Ketamine Space With Proposed Acquisition of Ketamine Infusion Centers of Texas
Vancouver, British Columbia, Canada – February 4, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) a biotechnology research...
Read more